Efficacy and Safety of Cagrilintide and Cagrisema Versus Semaglutide as Anti‐Obesity Medications: A Systematic Review, Meta‐Analysis and Meta‐Regression
Cagrisema is more effective than semaglutide in reducing weight and increasing glycemic control. Cagrisema is safe and has a comparable side effect profile to currently accepted treatments. This regimen has enormous potential in dual-agonist therapy for obese patients.
Authors
- Sabit Saad Shafiq (ORCID: https://orcid.org/0009-0005-3211-2044)
- Ammad Uddin
- Muhammad Nadeem Ahsan (ORCID: https://orcid.org/0000-0001-8701-0284)
- Muhammad Radzi Abu Hassan (ORCID: https://orcid.org/0000-0002-7971-1643)
- Mohammad Tahir (ORCID: https://orcid.org/0000-0002-6273-4603)
- Faisal Islam (ORCID: https://orcid.org/0000-0002-1471-1570)
- Mansoor Ahmed (ORCID: https://orcid.org/0000-0003-3880-9473)
- Muzna Hussain (ORCID: https://orcid.org/0000-0003-1533-6634)
- Ghulam Taha Khan (ORCID: https://orcid.org/0009-0003-5938-7297)
- Ahmed Ibrahim
- Saad Ahmed Waqas
Institutions
- Dow University of Health Sciences (PK)
- Ziauddin University (PK)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1111/dom.70667
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00